In a recent study, ultrasound (US) strain imaging was successfully used to identify and map tissue movement in the carpal tunnel, differentiating normal from abnormal nerve activity in the wrist, including carpal tunnel syndrome (CTS).

As the Radiological Society of North America (RSNA) celebrates 100 years as a community of innovators, leaders, researchers, educators and practitioners, the Research & Education (R&E) Foundation is launching a fundraising campaign to honor that milestone.

Kubtec has announced the FDA approval of the KUB 250, a portable low-dose digital x-ray system designed for the neonatal intensive care unit (NICU).

During my term as president of the Society of Nuclear Medicine (And Molecular Imaging, now appended), we were in the midst of the Molecular Imaging Campaign that was successful in increasing the visibility of nuclear medicine as a measure of physiologic and metabolic parameters in diagnosing our patients.

A year-to-date sales report for the radiopharmaceutical company Advanced Accelerator Applications (AAA) indicates that the company experienced 28.9 percent growth in sales, equaling about $68.7 million in the first nine months of 2014. Net income for the first three quarters of the year was gauged at approximately $1.5 million.

Targeting oncogene-driven activation of DNA damage could be an effective way to tap into the earliest stages of cancer development, or tumorigenesis. An investigative molecular imaging agent was able to do just that in a preclinical Oxford University study published ahead of print Nov. 13 in the Journal of Nuclear Medicine.

Navidea Biopharmaceuticals announced today that technetium-99m tilmanocept (Lymphoseek) has been approved by the European Commission for the detection of sentinel lymph node involvement in primary breast cancer, melanoma and localized squamous cell carcinoma.

Protea Biosciences, a biomedical company based in Morgantown, W. Va, announced yesterday that third quarter financial results amounted to $517,569, the highest revenue on record for the company. However net losses are still steep at more than $4.6 million for the third quarter.